CD4 and neoplasm: In melanoma, the ex vivo depletion of CCR4(+) T cells from the peripheral blood of patients and subsequent in vitro stimulation of the depleted cell population with a tumor antigen, led to augmentation of antigen-specific CD4(+) T cells [128].